Your browser doesn't support javascript.
loading
Wharton's jelly-mesenchymal stem cells treatment for severe COVID 19 patients: 1-year follow-up.
Saleh, Mahshid; Vaezi, Amir Abbas; Sohrabpour, Amir Ali; Barkhordar, Maryam; Aghaghazvini, Leila; Alijani, Neda; Verdi, Javad.
Afiliação
  • Saleh M; Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Vaezi AA; Department of internal medicine, Alborz University of Medical Sciences, Karaj, Iran.
  • Sohrabpour AA; Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Barkhordar M; Hematology, Oncology and Stem Cell Transplantation Research Center (HORCSCT), Tehran University of Medical Sciences, Tehran, Iran.
  • Aghaghazvini L; Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Alijani N; Department of lnfectious Diseases, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Verdi J; Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Gene Rep ; 29: 101691, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36373143

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Gene Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Gene Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã